The idea of being forced to offer discounts on drug prices to California state health programs upsets the pharmaceutical industry. In fact, some drug makers -- including Pfizer and Johnson & Johnson -- are so opposed to the idea that they have donated more than $10 million to fight a state ballot initiative that would impose price caps.
Read Full Article »
